Diabetics should clear out plenty of room in their medicine cabinets for their new gear, including (from left) disposable ...

MIRA Pharmaceuticals (MIRA) announced that its novel oral ketamine analog, Ketamir-2, has shown greater pain relief compared to FDA-approved ...

AstraZeneca and Ionis' drug Wainzua (eplontersen) has been recommended for approval in the European Union for treating ...

At his practice on-site at Lebanon Internal Medicine Associates, Dr. Fishman utilizes advanced technology now offering ...

Fewer Cognitive Side Effects: With the potential to avoid sedation and cognitive impairment, Ketamir-2 offers an improved ...

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the company will present its pivotal Phase 3 data on ...

Erectile dysfunction (ED) affects up to 66% of diabetic men globally, with risk factors like age, long-term diabetes, and ...

Lyka Labs shares rose as the company announced that it has received the CDSCO approval for manufacturing & marketing of of ...

Peripheral neuropathy, a condition affecting millions of people worldwide, can cause chronic pain, numbness, and weakness, ...

Mumbai: Alkem Laboratories Ltd. has entered into a licensing agreement with US-based Sonnet BioTherapeutics Holdings, Inc to ...

If you’re living with diabetes, learn why you may be at greater risk for opioid use (and misuse) and what to do about it.